(Hypertension. 1999;34:609-616.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Hypertension Research Laboratory, Alton Ochsner Medical Foundation (Y.O., H.O., E.D.F), New Orleans, La; and the Division of Hypertension and Cardiorenal Disease (H.M.), Departments of Medicine and Pathology (T.F.), Dokkyo University School of Medicine, Tochigi, Japan.
AbstractThis study was designed to investigate the relationship between apoptosis (programmed cell death) and coronary arterial remodeling in spontaneously hypertensive rats (SHR) following prolonged nitric oxide synthesis inhibition. In addition, we evaluated whether the development of coronary arterial smooth muscular cell apoptosis was related to hemodynamics or to vascular hypertrophy. Three groups of 20-week-old male SHR were investigated: controls, and two groups that received two doses of NG-nitro-L arginine (L-NAME, 50 mg/L and 80 mg/L) each for 3 weeks. Mean arterial pressure and total peripheral resistance index increased whereas cardiac index diminished with L-NAME. Pathohistological study demonstrated increased pericardiac fibrosis and coronary arterial injury score in the L-NAME group in a dose-dependent manner. The high dose of L-NAME (Group 3) produced myocardial infarction in 78% of the rats. The wall:lumen ratio of epicardial coronary arteries was greater in L-NAME treated SHR (0.23±0.02 versus 0.16±0.02; P<0.05) and was associated with markedly increased apoptosis (15.3±6 versus 1.9±1; P<0.05) without smooth muscle cell proliferation (PCNA positive cells). Apoptosis occurred predominantly in hypertrophic coronary arterial smooth muscular cells; myocardial infarction and ventricular fibrosis were exacerbated by impaired hemodynamics induced by L-NAME. These data suggest that coronary endothelial dysfunction and myocardial ischemic disease induced by L-NAME were responsible for apoptosis of coronary arterial smooth muscle cells, myocardial fibrosis, and infarction, all pathological findings that are consistent with what may be found in clinical hypertensive heart disease.
Key Words: apoptosis nitric oxide L-NAME microvascular remodeling myocardial infarction ventricular fibrosis myocardial hemodynamics spontaneously hypertensive rat
This article has been cited by other articles:
![]() |
I. F. Benter, M. H. M. Yousif, J. T. Anim, C. Cojocel, and D. I. Diz Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H684 - H691. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ono, Y. Ono, A. Takanohashi, H. Matsuoka, and E. D. Frohlich Apoptosis and Glomerular Injury After Prolonged Nitric Oxide Synthase Inhibition in Spontaneously Hypertensive Rats Hypertension, December 1, 2001; 38(6): 1300 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Casellas, A. Herizi, A. Artuso, A. Mimran, and B. Jover Candesartan prevents L-NAME-induced cardio-renal injury in spontaneously hypertensive rats beyond hypotensive effects Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S84 - S90. [Abstract] [PDF] |
||||
![]() |
T. R. Quinlan, D. Li, V. E. Laubach, E. G. Shesely, N. Zhou, and R. A. Johns eNOS-deficient mice show reduced pulmonary vascular proliferation and remodeling to chronic hypoxia Am J Physiol Lung Cell Mol Physiol, October 1, 2000; 279(4): L641 - L650. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Cox, H. S. Sood, M. J. Hunt, D. Chandler, J. R. Henegar, G. M. Aru, and S. C. Tyagi Apoptosis in the left ventricle of chronic volume overload causes endocardial endothelial dysfunction in rats Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1197 - H1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yu, S. Tian, L. Metheny-Barlow, L.-J. Chew, A. J. Hayes, H. Pan, G.-L. Yu, and L.-Y. Li Modulation of Endothelial Cell Growth Arrest and Apoptosis by Vascular Endothelial Growth Inhibitor Circ. Res., December 7, 2001; 89(12): 1161 - 1167. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |